<html>

    <head>
  <meta charset="utf-8">
  <title>Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure | Research Group at Uppsala University</title>
  <meta content="width=device-width, initial-scale=1" name="viewport">
  <meta content="Webflow" name="generator">
  <link href="/css/normalize.css" rel="stylesheet" type="text/css">
  <link href="/css/webflow.css" rel="stylesheet" type="text/css">
  <link href="/css/caramba.webflow.css?1709566361" rel="stylesheet" type="text/css">
  <script src="https://ajax.googleapis.com/ajax/libs/webfont/1.4.7/webfont.js"></script>
  <script type="text/javascript">
    WebFont.load({
      google: {
        families: ["Ubuntu:300,300italic,400,400italic,500,500italic,700,700italic","Raleway:regular,500,600,700,800,900"]
      }
    });
  </script>
  <script src="/js/modernizr.js" type="text/javascript"></script>
  <link href="/img/logos/caramba_header_logo.png" rel="shortcut icon" type="image/x-icon">
  <link href="/img/logos/caramba_header_logo.png" rel="apple-touch-icon">
  <script>
    (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
    (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
    m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
    })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

    ga('create', 'UA-86146183-1', 'auto');
    ga('send', 'pageview');
  </script>
</head>


    
  <div class="section-header" id="section-header">
    <div class="section-header-container w-container">
      <div class="navbar w-nav" data-animation="default" data-collapse="medium" data-contain="1" data-doc-height="1" data-duration="400" data-no-scroll="1">
        <div class="navbar-container w-container">
          <a class="navbar-brand w-nav-brand" href="/">
              <img class="navbar-logo" src="/img/logos/rect205.png" height="50">
          </a>
          <div class="navbar-menubutton w-nav-button">
            <div class="w-icon-nav-menu"></div>
          </div>
          <a class="navbar-uulogo-link" href="https://www.medsci.uu.se/caramba/" target="_blank"><img class="navbar-uulogo-img" src="/img/logos/uulogo_64x64.png"></a>
          <nav class="navbar-menu w-nav-menu" role="navigation" style="float: right">
              
              <a class="navbar-link w-nav-link" href="/project/">Projects</a>
              
              <a class="navbar-link w-nav-link" href="/people/">People</a>
              
              <a class="navbar-link w-nav-link" href="/publication/">Publications</a>
              
              
              
              <a class="navbar-link w-nav-link" href="/education/">Education</a>
              
              <a class="navbar-link w-nav-link" href="/about/">About</a>
              
          </nav>
        </div>
      </div>
    </div>
  </div>

              <div>
          <div class="section-content-container w-container content">

        <h1 style="font-size: 1.4em">Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure</h1>
        <p><a href="/publication">&larr; Back to publications</a></p>

        <p>Published: 2008-02-14</p>

        <h4>Formatted citation</h4>
        <p>
            Scholz B, Svensson M, Alm H, Sköld K, Fälth M, Kultima K, Guigoni C, Doudnikoff E, Li Q, Crossman AR, Bezard E, Andrén PE..
            <a href="http://dx.doi.org/10.1371/journal.pone.0001589" target="_blank">Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure</a>.
            <br><em>PLoS One</em>.
             (2008).
            DOI: <a href="http://dx.doi.org/10.1371/journal.pone.0001589" target="_blank">10.1371/journal.pone.0001589</a>
            
        </p>
        <h4>Abstract</h4>
        <p>L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinsons disease (PD) that result from a progressive sensitization through repeated L-dopa exposures. The MPTP macaque model was used to study the proteome in dopamine-depleted striatum with and without subsequent acute and chronic L-dopa treatment using two-dimensional difference in-gel electrophoresis (2D-DIGE) and mass spectrometry. The present data suggest that the dopamine-depleted striatum is so sensitive to de novo L-dopa treatment that the first ever administration alone would be able (i) to induce rapid post-translational modification-based proteomic changes that are specific to this first exposure and (ii), possibly, lead to irreversible protein level changes that would be not further modified by chronic L-dopa treatment. The apparent equivalence between first and chronic L-dopa administration suggests that priming would be the direct consequence of dopamine loss, the first L-dopa administrations only exacerbating the sensitization process but not inducing it.</p>

            </div>
</div>

      <div class="section-footer">
    <div class="section-footer-container w-container">
        
        <div class="footer-text">
            <p>
            <strong>CARAMBA Research Group</strong><br>
            Department of Medical Sciences<br>
            Uppsala University, Sweden<br>
            GitHub: <a href="https://github.com/caramba-uu">github.com/caramba</a>
            </p>
        </div>
    </div>
  </div>

  <script src="https://ajax.googleapis.com/ajax/libs/jquery/2.2.0/jquery.min.js" type="text/javascript"></script>
  <script src="/js/webflow.js" type="text/javascript"></script>
  
</body>
</html>

